Incidence of Central Venous Catheter-Related Infection and Risk Factors in Critically Ill Post-Operative Cancer Patients: A Randomized Prospective Cohort Study
Archives of Critical Care Medicine,
Vol. 1 No. 4 (2016),
28 October 2023
Abstract
Background: Cancer patients are susceptive to infection. Catheter-related bloodstream infections are the first cause of nosocomial bloodstream infections in intensive care units. Objectives: The aim of this study was to evaluate the association between the type of central intravenous catheter and bloodstream infection in post-operative cancer surgery patients at surgery intensive care units (ICU).
Methods: In a randomized, non-blind study, 66 cancer surgery patients were studied. The primary aim was rate of central venous catheter-related infection by type of catheter. The patients were enrolled in three groups: simple catheter (n = 23) (without antimi[1]crobial), impregnated catheter in the internal part (n = 28), and AGB + catheter (n = 15) (impregnated catheter in external and internal part); all catheters were triple lumen, polyurethane (arrow, chlorhexidine and silver sulfadiazine, USA). Insertion of catheters was done in full sterile conditions based on the center for disease control (CDC) guidelines for the prevention of intravascular catheter[1]related infection. Catheter related infection was confirmed by positive blood culture of blood samples of central catheter. The chi square or Fisher’s exact test was used to compare base values and difference in rate of colonization and bloodstream catheter-related infection. A P value of less than 0.05 was considered statistically significant.
Results: Sixty-six patients participated in this study in three groups. There was no significant difference regarding the baseline demographic and clinical characteristics of patients between groups (P > 0.05). Distributions of surgery types were statistically the same in the three groups (P = 0.323). Impregnated catheters had no significant effect on colonization (P = 0.565) or bloodstream infection prevention (P = 0.490).
Conclusions: Compared to standard catheters, impregnated catheters had no effect on colonization or bloodstream infection pre[1]vention.
- Cancer Patients
- Critically Ill
- Central Venous Catheter-Related Infection
How to Cite
References
Frasca D, Dahyot-Fizelier C, Mimoz O. Prevention of central venous catheter-related infection in the intensive care unit. Crit Care.
;14(2):212. doi: 10.1186/cc8853. [PubMed: 20236456].
Mermel LA. Prevention of intravascular catheter-related infections.
Ann Intern Med. 2000;132(5):391–402. [PubMed: 10691590].
Schiffer CA, Mangu PB, Wade JC, Camp-Sorrell D, Cope DG, El-Rayes BF,
et al. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin
Oncol. 2013;31(10):1357–70. doi: 10.1200/JCO.2012.45.5733. [PubMed:
.
Tomlinson D, Mermel LA, Ethier MC, Matlow A, Gillmeister B,
Sung L. Defining bloodstream infections related to central venous
catheters in patients with cancer: a systematic review. Clin Infect Dis.
;53(7):697–710. doi: 10.1093/cid/cir523. [PubMed: 21890775].
O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard
SO, et al. Guidelines for the prevention of intravascular catheterrelated infections. Am J Infect Control. 2011;39(4 Suppl 1):1–34. doi:
1016/j.ajic.2011.01.003. [PubMed: 21511081].
O’Grady NP, Alexander M, Dellinger EP. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis.
;35:1281–307.
Maki DG, Ringer M. Risk factors for infusion-related phlebitis with
small peripheral venous catheters. A randomized controlled trial.
Ann Intern Med. 1991;114(10):845–54. [PubMed: 2014945].
Sheth NK, Franson TR, Rose HD, Buckmire FL, Cooper JA, Sohnle PG.
Colonization of bacteria on polyvinyl chloride and Teflon intravascular catheters in hospitalized patients. J Clin Microbiol. 1983;18(5):1061–
[PubMed: 6643657].
Dettenkofer M, Ebner W, Bertz H, Babikir R, Finke J, Frank U, et al.
Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stemcell transplantation. Bone Marrow Transplant. 2003;31(9):795–801. doi:
1038/sj.bmt.1703920. [PubMed: 12732887].
Boersma RS, Jie KS, Verbon A, van Pampus EC, Schouten HC. Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol. 2008;19(3):433–
doi: 10.1093/annonc/mdm350. [PubMed: 17962211].
Salzman MB, Rubin LG. Intravenous catheter-related infections. Adv
Pediatr Infect Dis. 1995;10:337–68. [PubMed: 7718211].
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM,
et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care
Med. 2013;39(2):165–228. doi: 10.1007/s00134-012-2769-8. [PubMed:
.
Nieboer P, de Vries EG, Mulder NH, Rodenhuis S, Bontenbal M, van
der Wall E, et al. Factors influencing catheter-related infections in
the Dutch multicenter study on high-dose chemotherapy followed
by peripheral SCT in high-risk breast cancer patients. Bone Marrow
Transplant. 2008;42(7):475–81. doi: 10.1038/bmt.2008.195. [PubMed:
.
Ozyuvaci E, Kutlu F. Totally implantable venous access devices via subclavian vein: a retrospective study of 368 oncology patients. Adv Ther.
;23(4):574–81. [PubMed: 17050500].
Camargo LF, Marra AR, Buchele GL, Sogayar AM, Cal RG, de Sousa
JM, et al. Double-lumen central venous catheters impregnated with
chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised
study. J Hosp Infect. 2009;72(3):227–33. doi: 10.1016/j.jhin.2009.03.018.
[PubMed: 19443078].
Sousa C, Henriques M, Oliveira R. Mini-review: Antimicrobial central venous catheters–recent advances and strategies. Biofouling.
;27(6):609–20. doi: 10.1080/08927014.2011.593261. [PubMed:
.
Khalifa R, Dahyot-Fizelier C, Laksiri L, Ragot S, Petitpas F, Nanadoumgar H, et al. Indwelling time and risk of colonization of peripheral arterial catheters in critically ill patients. Intensive Care
Med. 2008;34(10):1820–6. doi: 10.1007/s00134-008-1139-z. [PubMed:
.
Raad I, Hanna HA, Awad A, Alrahwan A, Bivins C, Khan A, et al. Optimal frequency of changing intravenous administration sets: is it
safe to prolong use beyond 72 hours?. Infect Control Hosp Epidemiol.
;22(3):136–9. doi: 10.1086/501879. [PubMed: 11310690].
Macias AE. Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours?. Infect Control Hosp
Epidemiol. 2001;22(8):475–6. doi: 10.1086/503407. [PubMed: 11700869].
Gillies D, O’Riordan L, Wallen M, Rankin K, Morrison A, Nagy S. Timing of intravenous administration set changes: a systematic review.
Infect Control Hosp Epidemiol. 2004;25(3):240–50. doi: 10.1086/502385.
[PubMed: 15061417].
Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, et
al. Clinical and economic outcomes in critically ill patients with
nosocomial catheter-related bloodstream infections. Clin Infect Dis.
;41(11):1591–8. doi: 10.1086/497833. [PubMed: 16267731].
Halton KA, Cook DA, Whitby M, Paterson DL, Graves N. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision. Crit Care. 2009;13(2):35. doi:
1186/cc7744. [PubMed: 19284570].
Hockenhull JC, Dwan KM, Smith GW, Gamble CL, Boland A, Walley
TJ, et al. The clinical effectiveness of central venous catheters treated
with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review. Crit Care Med. 2009;37(2):702–
doi: 10.1097/CCM.0b013e3181958915. [PubMed: 19114884].
Crnich CJ, Maki DG. Are antimicrobial-impregnated catheters effective? Don’t throw out the baby with the bathwater. Clin Infect Dis.
;38(9):1287–92. doi: 10.1086/383470. [PubMed: 15127342].
Ramritu P, Halton K, Collignon P, Cook D, Fraenkel D, Battistutta
D, et al. A systematic review comparing the relative effectiveness
of antimicrobial-coated catheters in intensive care units. Am J Infect
Control. 2008;36(2):104–17. doi: 10.1016/j.ajic.2007.02.012. [PubMed:
.
Hentrich M, Schalk E, Schmidt-Hieber M, Chaberny I, Mousset S, Buchheidt D, et al. Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of
the German Society of Hematology and Medical Oncology. Ann Oncol.
;25(5):936–47. doi: 10.1093/annonc/mdt545. [PubMed: 24399078].
Mollee P, Jones M, Stackelroth J, van Kuilenburg R, Joubert W, Faoagali
J, et al. Catheter-associated bloodstream infection incidence and risk
factors in adults with cancer: a prospective cohort study. J Hosp Infect.
;78(1):26–30. doi: 10.1016/j.jhin.2011.01.018. [PubMed: 21459476].
Castagnola E, Ginocchio F. Rescue therapy of difficult-to-treat indwelling central venous catheter-related bacteremias in cancer patients: a review for practical purposes. Expert Rev Anti Infect Ther.
;11(2):179–86. doi: 10.1586/eri.12.160. [PubMed: 23409823].
Lai NM, Chaiyakunapruk N, Lai NA, O’Riordan E, Pau WSC, Saint S.
Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults (Review) The Cochrane Library; 2013. Available from: http://www.thecochranelibrary.co
- Abstract Viewed: 10 times
- PDF Downloaded: 0 times